Table 1.
Patient demographic and clinical data.
| Patient Characteristics | Xpert TB-positive | |
|---|---|---|
| Xpert rifampicin-susceptible (n = 56) | Xpert rifampicin -resistant (n = 29) | |
| Age, median (IQR) | 40 (30–49) | 35 (23–42; p = 0.086) |
| Male gender (%) | 37/55 (67)* | 12/20 (60)* |
| Smear-positivity (%) | 37/50 (74)* | 6/16 (38)* |
| Culture-positivity (%) | Not done | 19/21 (90)* |
| TTP, median (IQR) | N/A | 10 (8–20) |
| Xpert CT, median IQR | 17.9 (16.3–22.1) | 20.5 (16.9–24.8) |
*Missing data: Gender (n = 1 for RIF-susceptible, n = 9 for RIF-resistant); Smear status (n = 6 for Xpert RIF susceptible, n = 13 for Xpert RIF-resistant); Culture results (n = 8 for RIF-resistant results). Abbreviations: Xpert - Xpert MTB/RIF; IQR - interquartile range; TTP - time-to-positivity; CT - cycle threshold values.